首页> 外文OA文献 >How artificial intelligence tools can be used to assess individual patient risk in cardiovascular disease: problems with the current methods

【2h】

How artificial intelligence tools can be used to assess individual patient risk in cardiovascular disease: problems with the current methods

机译：如何使用人工智能工具评估个人患心血管疾病的风险：当前方法的问题

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Enzo Grossi;
展开▼
作者单位

展开▼
年度 2006
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Computer-Aided Diagnosis and Clinical Trials of Cardiovascular Diseases Based on Artificial Intelligence Technologies for Risk-Early Warning Model [J] . Li Bin, Ding Shuai, Song Guolei, Journal of medical systems . 2019,第7期

机译：基于人工智能技术风险预警模型的计算机辅助诊断和临床试验
2. Association of renal damage with cardiovascular diseases is independent of individual cardiovascular risk profile in hypertension: data from the Italy - Developing Education and awareness on MicroAlbuminuria in patients with hypertensive Disease study. [J] . Sciarretta S, Valenti V, Tocci Journal of hypertension . 2010,第2期

机译：肾脏损害与心血管疾病的关联与高血压的个人心血管风险状况无关：来自意大利的数据-高血压病患者对微量白蛋白尿的发展教育和认识。
3. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial. [J] . Wood DA, Kotseva K, Connolly S, The Lancet . 2008,第9629期

机译：由护士协调的基于家庭的多学科心血管疾病预防计划（EUROACTION），用于冠心病患者和无症状心血管疾病高风险患者：一项配对，整群随机对照试验。
4. How overcome some pitfalls of present methods to assess the individual absolute risk for major cardiovascular events thanks to artificial intelligence tools [C] . Grossi, E. . 2006

机译：借助人工智能工具，如何克服当前方法在评估重大心血管事件的个人绝对风险方面的一些陷阱
5. Role of patients' perception of barriers to taking medication on medication adherence among patients with diabetes: Development and psychometric evaluation of the Murage-Marrero- Monahan Medication barriers scale (4M scale), patient characteristics associated with medication barriers, and association of medication barriers and cardiovascular disease (CVD) risk. [D] . Murage, Mwangi James. 2014

机译：糖尿病患者对患者服药障碍的感知对药物依从性的作用：Murage-Marrero-Monahan药物障碍量表（4M量表），与药物障碍相关的患者特征以及药物障碍和心血管疾病（CVD）的风险。
6. How artificial intelligence tools can be used to assess individual patient risk in cardiovascular disease: problems with the current methods [O] . Enzo Grossi 2006

机译：如何使用人工智能工具评估个人患心血管疾病的风险：当前方法的问题
7. How artificial intelligence tools can be used to assess individual patient risk in cardiovascular disease: problems with the current methods [O] . Grossi Enzo 2006

机译：如何使用人工智能工具评估个人患心血管疾病的风险：当前方法的问题

How artificial intelligence tools can be used to assess individual patient risk in cardiovascular disease: problems with the current methods

著录项

引文网络

相似文献

相关主题

期刊订阅